Rafferty Asset Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.37M Sell
78,734
-12,400
-14% -$235K 0.01% 693
2025
Q4
$1.72M Sell
91,134
-1,364
-1% -$22.9K 0.01% 685
2025
Q3
$1.34M Buy
92,498
+21,129
+30% +$301K ﹤0.01% 731
2025
Q2
$1.39M Sell
71,369
-27,960
-28% -$497K ﹤0.01% 696
2025
Q1
$1.76M Sell
99,329
-20,469
-17% -$441K 0.01% 608
2024
Q4
$2.56M Buy
119,798
+51,559
+76% +$1.25M 0.01% 575
2024
Q3
$2.13M Sell
68,239
-21,195
-24% -$527K 0.01% 618
2024
Q2
$1.39M Sell
89,434
-275,365
-75% -$3.33M 0.01% 742
2024
Q1
$3.86M Buy
364,799
+174,401
+92% +$1.74M 0.01% 522
2023
Q4
$2.28M Sell
190,398
-114,886
-38% -$941K 0.01% 638
2023
Q3
$2.14M Sell
305,284
-37,671
-11% -$348K 0.01% 594
2023
Q2
$2.92M Sell
342,955
-64,392
-16% -$537K 0.02% 536
2023
Q1
$3.72M Sell
407,347
-78,036
-16% -$998K 0.03% 456
2022
Q4
$5.54M Buy
485,383
+193,438
+66% +$2.87M 0.05% 356
2022
Q3
$4.97M Buy
291,945
+123,736
+74% +$2.66M 0.05% 338
2022
Q2
$3.61M Sell
168,209
-5,523
-3% -$153K 0.03% 350
2022
Q1
$6.43M Buy
173,732
+50,988
+42% +$1.99M 0.04% 303
2021
Q4
$5.58M Buy
122,744
+77,882
+174% +$4.07M 0.03% 345
2021
Q3
$2.84M Buy
44,862
+16,275
+57% +$1.24M 0.02% 512
2021
Q2
$2.62M Sell
28,587
-20,756
-42% -$1.65M 0.02% 571
2021
Q1
$3.36M Buy
49,343
+35,821
+265% +$2.78M 0.02% 416
2020
Q4
$980K Sell
13,522
-35,856
-73% -$2.08M 0.01% 499
2020
Q3
$1.87M Buy
49,378
+26,715
+118% +$902K 0.02% 437
2020
Q2
$803K Buy
22,663
+12,075
+114% +$344K 0.01% 602
2020
Q1
$231K Sell
10,588
-79,341
-88% -$1.78M 0.01% 491
2019
Q4
$1.94M Sell
89,929
-110,648
-55% -$2.54M 0.03% 401
2019
Q3
$4.54M Buy
200,577
+80,986
+68% +$2.24M 0.07% 163
2019
Q2
$4.3M Buy
119,591
+37,543
+46% +$1.2M 0.08% 197
2019
Q1
$2.59M Buy
+82,048
New +$2.39M 0.04% 273

Other funds holding CDNA